Anti-Tumor Effects of Mfn2 in Gastric Cancer

Cell cycle regulation by the intrinsically disordered proteins p21 and p27

(2012) Mi-Kyung Yoon et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Intrinsic disorder mediates the diverse regulatory functions of the Cdk inhibitor p21

(2011) Yuefeng Wang et al.   Nature Chemical Biology

Molecular targeted agents for gastric and gastroesophageal junction cancer

(2011) Takashi Oshima et al.   SURGERY TODAY

MFN2point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families

(2010) Geir J Braathen et al.   BMC Medical Genetics

A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells

(2010) Hao Liu et al.   CANCER LETTERS

Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma

(2010) Baiye Jin et al.   MEDICAL ONCOLOGY

Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells

(2010) Weilin Wang et al.   MEDICAL ONCOLOGY

Mcl-1 Integrates the Opposing Actions of Signaling Pathways That Mediate Survival and Apoptosis

(2009) C. Morel et al.   MOLECULAR AND CELLULAR BIOLOGY

Activation of the Osteopontin/Matrix Metalloproteinase-9 Pathway Correlates with Prostate Cancer Progression

(2008) G. Castellano et al.   CLINICAL CANCER RESEARCH

Molecular Machinery of Mitochondrial Fusion and Fission

(2008) Benedikt Westermann   JOURNAL OF BIOLOGICAL CHEMISTRY

Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells

(2008) L. Wu et al.   MOLECULAR CANCER THERAPEUTICS

Mitofusin 2 tethers endoplasmic reticulum to mitochondria

(2008) Olga Martins de Brito et al.   NATURE

Mitofusin 2: A Mitochondria-Shaping Protein with Signaling Roles Beyond Fusion

(2007) Olga Martins de Brito et al.   ANTIOXIDANTS & REDOX SIGNALING